Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)
Influence of Total Atherosclerotic Burden Assessed by 3-vessel Fractional Flow Reserve (FFR) on the Clinical Outcomes of the Patients With Multi-vessel Disease
1 other identifier
observational
1,136
5 countries
20
Brief Summary
This study will evaluate the influence of total atherosclerotic burden assessed by 3-vessel fractional flow reserve (FFR) on the clinical outcomes of the patients with multi-vessel disease. For this purpose, the clinical data of the patients with 3-vessel intermediate coronary artery disease, whose FFR was measured at all 3-vessels due to their own clinical needs, will be analyzed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2012
Longer than P75 for all trials
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 7, 2012
CompletedFirst Posted
Study publicly available on registry
June 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedAugust 25, 2017
August 1, 2017
2.8 years
June 7, 2012
August 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The rate of the composite of major adverse cardiac events (MACE: cardiac death, myocardial infarction, revascularization) at 2 years per 3-vessel FFR
2 years after FFR measurement
Eligibility Criteria
The patients with 3-vessel intermediate coronary artery disease (visually 30\~70% stenosis in coronary angiogram) whose FFR was measured at all 3-vessels due to their own clinical needs.
You may qualify if:
- Subject must be at least 18 years of age.
- Subject must have stenosis (\>30% by visual estimate) in all 3-epicardial coronary arteries.
- FFR should be measured at all 3-vessels at the end of a procedure.
You may not qualify if:
- Depressed left ventricular systolic function (ejection fraction \< 35%)
- ST-elevation myocardial infarction within 72 hours,
- Prior coronary artery bypass graft surgery
- Creatinine level \>= 2.0mg/dL or dependence on dialysis
- Abnormal final myocardial flow (TIMI flow \< 3)
- Planned bypass surgery
- Failed FFR measurement
- Failed intended revascularization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seoul National University Hospitallead
- Samsung Medical Centercollaborator
- Keimyung University Dongsan Medical Centercollaborator
- Inje Universitycollaborator
- Fu Wai Hospital, Beijing, Chinacollaborator
- The First Affiliated Hospital with Nanjing Medical Universitycollaborator
- Second Affiliated Hospital, School of Medicine, Zhejiang Universitycollaborator
- Guangdong Provincial People's Hospitalcollaborator
- Tokyo medical college hospital, Japancollaborator
- Kokura Memorial Hospitalcollaborator
- Gifu Heart Centercollaborator
- Aichi Medical Universitycollaborator
- Wakayama Medical Universitycollaborator
- Queen Mary Hospital, Hong Kongcollaborator
- United Christian Hospitalcollaborator
- National University Heart Centre, Singaporecollaborator
- National Taiwan University Hospitalcollaborator
- Nagoya Daini Nesseki Hospitalcollaborator
- Ulsan University Hospitalcollaborator
- Ajou University School of Medicinecollaborator
Study Sites (20)
Fuwai hospital
Beijing, China
Guandong general hospital
Guandong, China
Queen Mary Hospital, The University of Hong Kong
Hong Kong, China
United Christian Hospital
Hong Kong, China
Nanjing 1st hospital
Nanjing, China
Zhejiang No 2 hospital
Zhejiang, China
Gifu heart center
Gifu, Japan
Kokura memorial hospital
Kitakyushu, Japan
2nd Red Cross hospital
Kyoto, Japan
Aichi Medical university hospital
Nagakute, Japan
Tokyo medical college hospital
Tokyo, Japan
Wakayama medical university
Wakayama, Japan
National University Heart center
Singapore, Singapore
Keimyung University Dongsan medical center
Daegu, South Korea
Inje university Ilsan Paik hospital
Ilsan, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital, Seoul, Korea
Seoul, South Korea
Ajou university hospital
Suwon, South Korea
Ulsan university hospital
Ulsan, South Korea
National Taiwan University hospital
Taipei, Taiwan
Related Publications (9)
Lee JM, Lee SH, Hwang D, Rhee TM, Choi KH, Kim J, Park J, Kim HY, Jung HW, Cho YK, Yoon HJ, Song YB, Hahn JY, Nam CW, Shin ES, Doh JH, Hur SH, Koo BK. Long-Term Clinical Outcomes of Nonhyperemic Pressure Ratios: Resting Full-Cycle Ratio, Diastolic Pressure Ratio, and Instantaneous Wave-Free Ratio. J Am Heart Assoc. 2020 Sep 15;9(18):e016818. doi: 10.1161/JAHA.120.016818. Epub 2020 Sep 11.
PMID: 32914672DERIVEDLee JM, Choi KH, Koo BK, Park J, Kim J, Hwang D, Rhee TM, Kim HY, Jung HW, Kim KJ, Yoshiaki K, Shin ES, Doh JH, Chang HJ, Cho YK, Yoon HJ, Nam CW, Hur SH, Wang J, Chen S, Kuramitsu S, Tanaka N, Matsuo H, Akasaka T. Prognostic Implications of Plaque Characteristics and Stenosis Severity in Patients With Coronary Artery Disease. J Am Coll Cardiol. 2019 May 21;73(19):2413-2424. doi: 10.1016/j.jacc.2019.02.060.
PMID: 31097161DERIVEDKim CH, Koo BK, Lee JM, Shin ES, Park J, Choi KH, Hwang D, Rhee TM, Zhang J, Choi YJ, Lee SY, Choi JH, Doh JH, Nam CW, Wang J, Chen S, Kuramitsu S, Tanaka N, Matsuo H, Akasaka T. Influence of Sex on Relationship Between Total Anatomical and Physiologic Disease Burdens and Their Prognostic Implications in Patients With Coronary Artery Disease. J Am Heart Assoc. 2019 Mar 5;8(5):e011002. doi: 10.1161/JAHA.118.011002.
PMID: 30813812DERIVEDLee JM, Choi KH, Park J, Hwang D, Rhee TM, Kim J, Park J, Kim HY, Jung HW, Cho YK, Yoon HJ, Song YB, Hahn JY, Nam CW, Shin ES, Doh JH, Hur SH, Koo BK. Physiological and Clinical Assessment of Resting Physiological Indexes. Circulation. 2019 Feb 12;139(7):889-900. doi: 10.1161/CIRCULATIONAHA.118.037021.
PMID: 30586749DERIVEDPark J, Lee JM, Koo BK, Shin ES, Nam CW, Doh JH, Hwang D, Zhang J, Hu X, Wang J, Ye F, Chen S, Yang J, Chen J, Tanaka N, Yokoi H, Matsuo H, Takashima H, Shiono Y, Akasaka T. Clinical Relevance of Functionally Insignificant Moderate Coronary Artery Stenosis Assessed by 3-Vessel Fractional Flow Reserve Measurement. J Am Heart Assoc. 2018 Feb 15;7(4):e008055. doi: 10.1161/JAHA.117.008055.
PMID: 29449274DERIVEDChoi KH, Lee JM, Koo BK, Nam CW, Shin ES, Doh JH, Rhee TM, Hwang D, Park J, Zhang J, Kim KJ, Hu X, Wang J, Ye F, Chen S, Yang J, Chen J, Tanaka N, Yokoi H, Matsuo H, Takashima H, Shiono Y, Akasaka T. Prognostic Implication of Functional Incomplete Revascularization and Residual Functional SYNTAX Score in Patients With Coronary Artery Disease. JACC Cardiovasc Interv. 2018 Feb 12;11(3):237-245. doi: 10.1016/j.jcin.2017.09.009. Epub 2018 Jan 17.
PMID: 29361444DERIVEDKobayashi Y, Lee JM, Fearon WF, Lee JH, Nishi T, Choi DH, Zimmermann FM, Jung JH, Lee HJ, Doh JH, Nam CW, Shin ES, Koo BK. Three-Vessel Assessment of Coronary Microvascular Dysfunction in Patients With Clinical Suspicion of Ischemia: Prospective Observational Study With the Index of Microcirculatory Resistance. Circ Cardiovasc Interv. 2017 Nov;10(11):e005445. doi: 10.1161/CIRCINTERVENTIONS.117.005445.
PMID: 29146670DERIVEDLee JM, Koo BK, Shin ES, Nam CW, Doh JH, Hu X, Ye F, Chen S, Yang J, Chen J, Tanaka N, Yokoi H, Matsuo H, Takashima H, Shiono Y, Hwang D, Park J, Kim KJ, Akasaka T, Wang J. Clinical Outcomes of Deferred Lesions With Angiographically Insignificant Stenosis But Low Fractional Flow Reserve. J Am Heart Assoc. 2017 Aug 22;6(8):e006071. doi: 10.1161/JAHA.117.006071.
PMID: 28862970DERIVEDLee JM, Kim CH, Koo BK, Hwang D, Park J, Zhang J, Tong Y, Jeon KH, Bang JI, Suh M, Paeng JC, Cheon GJ, Na SH, Ahn JM, Park SJ, Kim HS. Integrated Myocardial Perfusion Imaging Diagnostics Improve Detection of Functionally Significant Coronary Artery Stenosis by 13N-ammonia Positron Emission Tomography. Circ Cardiovasc Imaging. 2016 Sep;9(9):e004768. doi: 10.1161/CIRCIMAGING.116.004768.
PMID: 27609817DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bon-Kwon Koo, MD
Cardiovascular Center, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, South Korea
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 7, 2012
First Posted
June 18, 2012
Study Start
May 1, 2012
Primary Completion
March 1, 2015
Study Completion
September 1, 2018
Last Updated
August 25, 2017
Record last verified: 2017-08